•  12/1/2020 06:27 AM

Hyperglycemia at hospital admission — regardless of diabetes status — is a key predictor of COVID-19-related death and severity among noncritical patients, new research from Spain finds. The observational study, the largest to date to investigate this association, was published online November 23 in Annals of Medicine by Francisco Javier Carrasco-Sánchez, MD, PhD, and colleagues.

Read More
  •  11/30/2020 08:52 AM

The government is paying about $30 million, or Tk 260 crore, more than the price set by AstraZeneca to buy three crore doses of the Oxford COVID-19 vaccine from its manufacturer Serum Institute of India through its local vendor Beximco Pharmaceuticals.

Read More
  •  11/27/2020 10:25 AM

MOSCOW: Indian pharmaceutical company Hetero will manufacture over 100 million doses of the Russian Sputnik V COVID-19 vaccine per year under the terms of a deal unveiled on Friday between it and Russia’s RDIF sovereign wealth fund.

Read More
  •  11/27/2020 09:19 AM

For so many, 2020 has been a bleak year filled with uncertainty and anxiety directly related to the COVID-19 pandemic that has surged across the globe and led to the deaths of more than 1.4 million people, including close to 260,000 in the United States.

Read More
  •  11/25/2020 09:44 AM

Industry experts and observers opine that the demand for repurposed drugs are likely to continue for some time even after the COVID-19 vaccines come to the Indian market. They point out that due to the large size of the population in the country and anticipated challenges associated with the COVID-19 vaccine supply chain it will take considerable time until the entire nation gets vaccinated.

Read More
  •  11/24/2020 01:35 AM

The British drug maker said on Monday that the vaccine could be around 90% effective, when administered as a half dose followed by a full dose a month later, citing data from late-stage trials in Britain and Brazil.

Read More
  •  11/24/2020 12:23 AM

Regeneron’s COVID-19 monoclonal antibody cocktail that was used to treat President Donald Trump has finally received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).

Read More
  •  11/18/2020 01:17 AM

Inovio Pharmaceuticals has received US FDA’s approval to commence a mid-stage study of its COVID-19 vaccine candidate. The trial for the vaccine, INO-4800, will be funded by the US Department of Defense, the company said.

Read More
  •  11/17/2020 12:18 AM

Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic

Read More
  •  11/17/2020 12:06 AM

Only a week after Pfizer and BioNTech’s preliminary data readout of its COVID-19 vaccine suggested a 90% efficacy rate, Moderna reported interim efficacy data for its vaccine of 94.5%. This is particularly excellent news given the surge of the disease and the distribution difficulties surrounding the Pfizer-BioNTech effort.

Read More
  •  11/16/2020 04:34 AM

The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate. This includes an initial order for 200 million doses for all EU Member States, as well as an additional option to purchase another 100 million doses of the vaccine if it is proven to be safe and effective against COVID-19.

Read More
  •  11/16/2020 02:20 AM

Most adults with moderate-to-severe COVID-19 have a suppressed immune response against the novel coronavirus rather than life-threatening hyper-inflammation, according to a study which suggests steroids such as dexamethasone should be reserved for the sickest patients

Read More